Parkinson's Disease Trial, Recruiting NCT07308418 Sponsor: Magnes AG Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07308418
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been officially diagnosed with Parkinson's disease by a doctor, as confirmed on a physiotherapy prescription.
  • Your Parkinson's medication has stayed the same for at least four weeks, with no changes to your dopamine-related treatment.
  • You are able to walk at least 200 metres (roughly two city blocks) without stopping.
  • You are 18 years of age or older.
  • You have a good enough understanding of German to read the study information and fill in questionnaires.
  • You are willing and able to sign a written consent form agreeing to take part.

Who may not be able to join:

  • You have been diagnosed with an atypical or secondary form of Parkinsonism (a related but different condition to standard Parkinson's disease).
  • You have reduced or altered sensation in your feet, such as a condition called polyneuropathy.
  • You have another neurological, bone/joint, or internal health condition that significantly affects how you walk.
  • You have memory or thinking difficulties that would make it hard to understand the study instructions or follow them during the trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +41442234873

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Magnes AG
Registry
ClinicalTrials.gov
Start date
10 January 2026
Est. completion
1 May 2026

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Change in self-selected walking speed (m/s); Change in self-selected gait speed

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov